CD4 and rheumatoid arthritis: Since this inhibitory effect of UBASH3A on proinflammatory cytokine production was observed in CD4+ T cells of both the control and RA patients (Fig. 5), it is unlikely that UBASH3A is associated with the pathogenic state of RA.